SEC Form 4 · accession 0001567619-18-003212
Medpace Holdings, Inc. · MEDP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Medpace Investors, LLC
10% Owner
Period of report
Sep 25, 2018
Accepted (ET)
Sep 27, 2018 · 4:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001668397
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Sep 25, 2018 | S | 38,640 | $58.36 | D | 8,989,174 | D | |
| Common StockF1,F3 | Sep 26, 2018 | S | 46,886 | $58.38 | D | 8,942,288 | D | |
| Common StockF1,F4 | Sep 27, 2018 | S | 46,778 | $58.96 | D | 8,895,510 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 20, 2018.
- F2The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $58.00 to $58.82. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
- F3The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $58.00 to $59.29. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
- F4The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $58.00 to $59.49. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.